Innate immune system damage in human immunodeficiency virus type 1 infection: Implications for acquired immunity and vaccine design

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 4 II, 2000, Pages

  Howie, Sarah ^a,b   Ramage, Robert ^a   Hewson, Tim ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; SYNTHETIC PEPTIDE;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CONFERENCE PAPER; DRUG DESIGN; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; IMMUNITY; MACROPHAGE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033763080     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.supplement_3.15tac1     Document Type: Conference Paper

References (48)

1. World Health Organisation statistics
2. Interactions of HIV-I with antigen-presenting cells
3. Immunologic effects of HIV in the lung
4. Decreased exhaled nitric oxide in subjects with HIV infection
5. Continuous nitric-oxide synthesis by inducible nitric-oxide synthase in normal human airway epithelium in-vivo
6. Human immunodeficiency virus-1-infected macrophages induce inducible nitric oxide synthase and nitric oxide (NO) production in astrocytes: A strocytic NO as a possible mediator of neural damage in acquired immunodeficiency syndrome
7. Erythrocyte glutathione deficiency in symptom-free HIV infection is associated with decreased synthesis rate
8. Pneumocystis-carinii pneumonia in HIV-infected patients effects of the diseases on glutathione and glutathione disulfide
9. Alveolar fluid glutathione decreases in asymptomatic HIV-seropositive subjects over time
10. Major histocompatibility complex genes influence the outcome of HIV-infection ancestral haplotypes with C4 null alleles explain diverse HLA associations
11. Prolonged clinically asymptomatic evolution after HIV-1 infection is marked by the absence of complement-C4 null alleles at the MHC
12. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-hinding lectin
13. Tumour necrosis factor c2 microsatellite allele is associated with the rate of HIV disease progression
14. Polymorphisms within the human tumor necrosis factor-alpha promoter region in human immunodeficiency virus type 1-seropositive persons
15. The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection
16. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression
17. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
18. CC chemokine receptor 5-mediated signaling and HIV-1 co-receptor activity share common structural determinants critical residues in the third extracellular loop support HIV-1 fusion
19. Antibodies to several conformation-dependent epitopes of gp120/gp41 inhibit CCR-5-dependent cell-to-cell fusion mediated by the native envelope glycoprotein of a primary macrophage-tropic HIV-1 isolate
20. Biological phenotype of human-immunodeficiency-virus type-1 clones at different stages of infection - Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations
21. Host factors in the pathogenesis of HIV disease
22. Productive human-immunodeficiency-virus type-1 (HIV-1) infection of nonproliferating human monocytes
23. GM-CSF and its effects on replication of HIV-1 in cells of macrophage lineage
24. Granulocyte-macrophage colony-stimulating factor down-regulates CD14 expression on monocytes
25. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding-protein
26. Antigen-specific apoptosis in immortalized T cells by soluble MHC class II-peptide complexes
27. Interferon induction by HIV glycoprotein-120 role of the V3 loop
28. Interferon induction by HIV-1-infected cells: A possible role of sulfatides or related glycolipids
29. A Th1-Th2 switch is a critical step in the etiology of HIV infection
30. Ability of HIV to promote a T(h)1 to T(h)0 shift and to replicate preferentially in T(h)2 and T(h)0 cells
31. Th1 cells specific for HIV-1 gag p24 are less efficient than Th0 cells in supporting HIV replication, and inhibit virus-replication in Th0 cells
32. Single-cell analysis of IL-4 and IFN-gamma production by T cells from HIV-infected individuals - Decreased IFN-gamma in the presence of preserved IL-4 production
33. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry
34. IL-10 up-regulates CCR5 gene expression in human monocytes
35. The effects of HIV gp120 on the expression of antigen presenting cell (APC) surface molecules
36. Bone marrow-derived dendritic cells, infection with human immunodeficiency virus, and immunopathology
37. Virus-induced autoimmunity
38. Low CD83, but normal MHC class II and costimulatory molecule expression, on spleen dendritic cells from HIV+ patients
39. Functionally relevant changes occur in HIV-infected individuals' alveolar macrophages prior to the onset of respiratory disease
40. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes
41. Priming of human CD4(+) antigen-specific T cells to undergo apoptosis by HIV-infected monocytes a two-step mechanism involving the gp120 molecule
42. Design and synthesis of a highly immunogenic discontinuous epitope of HIV-1 gp120 which binds to CD4+ve transfected cells
43. Immunological ignorance of silent antigens as an explanation of tumor evasion
44. A functional discontinuous HIV-1 gp120 C3/C4 domain-derived, branched, synthetic peptide that binds to CD4 and inhibits MIP-1 alpha chemokine binding
45. Single amino acid changes in HIV envelope affect viral tropism and receptor binding
46. Identification of individual human immundeficiency vires type-1 gp120 amino acids important for CD4 receptor binding
47. HIV molecular immunology database